LADENBURG, Germany,
July 8, 2024 /PRNewswire/
-- New4med GmbH, a German startup focused on innovative
spinal treatments, announces the successful European market launch
of its novel Basivertebral Nerve Ablation (BVNA) therapy.
BVNA is a treatment for vertebrogenic pain, a type of chronic
low back pain associated with bony lesions on the vertebral
endplates. The system, approved in Europe, is a minimally invasive, implant-free
procedure that can be performed on both inpatient and outpatient
bases. It uses targeted radiofrequency energy to block the Nervus
basivertebralis from transmitting pain signals to the brain, aiming
to improve function and provide sustainable relief.
"By offering BVNA to physicians, we are providing access to this
unique treatment for people with vertebrogenic pain in Europe for the first time," said Daniel Seifert, Shareholder and designated CEO
of New4med. "Our goal is to make this high-growth therapeutic
option available to a broad population of people with chronic low
back pain."
"The revolutionary Basivertebral Nerve Ablation has tremendous
potential to help even more people living with chronic pain," said
Prof. Robert Pflugmacher,
Mechernich. "Access to this form of therapy now significantly
enhances our treatment spectrum in the field of interventional
chronic pain management." comments Prof. Andreas Kurth, a pioneer in the treatment of
spinal metastasis with RF technology.
"We will continue to invest in developing our infrastructure to
ensure the broadest possible market access and to meet the growing
demand for this treatment." explained Eric
Schaber, Shareholder and Strategy Consultant. "This launch
is the beginning of a series of new unique extremely innovative
approaches that have the chance to revolutionize the current
treatment options in spinal surgery" adds Eric Schaber.
About New4med
New4med GmbH is a german medtech company
specializing in the development and distribution of innovative
products and procedures in spinal surgery. The product range aims
to treat chronic back pain in the spine, improving patients'
quality of life sustainably. New4med's experienced team consists of
professionals from the medtech industry who bring their expertise
and passion for innovation to the development and distribution of
their products. New4med prides itself on improving the quality of
life for millions of people worldwide.
For more information, visit our website at www.new4med.com.
Contact
Daniel
Seifert
d.seifert@new4med.com
+49 174 – 666 66 47
Photo - https://mma.prnewswire.com/media/2454767/New4Med.jpg
Logo -
https://mma.prnewswire.com/media/2454766/New4Med_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/new4med-gmbh-announces-first-cases-of-its-novel-basivertebral-nerve-ablation-bvna-302189957.html